Skip to content
2000
Volume 24, Issue 3
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Introduction

Exogenous melatonin (exo-MLT) is a sleep-promoting agent that modulates key sleep-wake neurotransmitters.

Methods

This scoping review analyzed 623 studies retrieved from PubMed/MEDLINE and ISI/Web of Science, applying PRISMA methodology to ensure rigorous inclusion criteria. After screening, 58 original research papers were analyzed for exo-MLT's effects on gamma-aminobutyric acid (GABA), serotonin, dopamine, glutamine, norepinephrine, epinephrine, orexin, acetylcholine, adenosine, glycine, galanin, and histamine.

Results

We identified 20 studies on the GABAergic system, showing that exo-MLT enhances GABA activity through different mechanisms, promoting non-REM sleep and reducing stress-related hyperarousal. On serotonin, 16 studies revealed limited and variable effects depending on the dose and physiological conditions. Total 13 dopamine studies suggested that exo-MLT does not alter physiological dopamine turnover, restoring dopaminergic balance in pathological states. On the glutamatergic system, seven studies showed a compensatory role of exo-MLT on glutamate excitotoxicity. Six studies on norepinephrine highlighted exo-MLT's ability to regulate sympathetic activity. The orexinergic system was the focus of five studies, indicating exo-MLT's inhibitory action on orexinergic neurons, enhancing sleep quality and consolidation. Five studies investigated exo-MLT on the cholinergic system, revealing an enhancing effect on acetylcholine activity in physiological and pathophysiological conditions. Lastly, four studies exploring adenosine and glycine were inconclusive of the exo-MLT effect, while we could not find any data on histamine and galanin.

Discussion

This review underscores exo-MLT's mechanisms beyond circadian regulation, offering therapeutic promise in sleep disorders associated with other neuropsychiatric conditions.

Conclusion

Exo-MLT’s interactions provide insights into its safety and non-addictive characteristics, supporting its integration into personalized sleep medicine.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X379708250702084616
2025-07-22
2026-03-01

  • From This Site

    /content/journals/cn/10.2174/011570159X379708250702084616
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Le BonO. Relationships between REM and NREM in the NREM-REM sleep cycle: A review on competing concepts.Sleep Med.20207061610.1016/j.sleep.2020.02.004 32179430
     [Google Scholar]
  2. RobbinsR. QuanS. Sleep health.NEJM Evid.202438EVIDra230026910.1056/EVIDra2300269
     [Google Scholar]
  3. Cruz-SanabriaF. CarmassiC. BrunoS. BazzaniA. CarliM. ScarselliM. FaragunaU. Melatonin as a chronobiotic with sleep-promoting properties.Curr. Neuropharmacol.202321495198710.2174/1570159X20666220217152617 35176989
     [Google Scholar]
  4. MatsumotoM. SackR.L. BloodM.L. LewyA.J. The amplitude of endogenous melatonin production is not affected by melatonin treatment in humans.J. Pineal Res.1997221424410.1111/j.1600‑079X.1997.tb00301.x 9062869
     [Google Scholar]
  5. BothorelB. BarassinS. SaboureauM. PerreauS. Vivien-RoelsB. MalanA. PévetP. In the rat, exogenous melatonin increases the amplitude of pineal melatonin secretion by a direct action on the circadian clock.Eur. J. Neurosci.20021661090109810.1046/j.1460‑9568.2002.02176.x 12383238
     [Google Scholar]
  6. ZisapelN. TarraschR. LaudonM. The relationship between melatonin and cortisol rhythms: Clinical implications of melatonin therapy.Drug Dev. Res.200565311912510.1002/ddr.20014
     [Google Scholar]
  7. ManninoG. PerniciC. SerioG. GentileC. BerteaC.M. Melatonin and phytomelatonin: Chemistry, biosynthesis, metabolism, distribution and bioactivity in plants and animals: An overview.Int. J. Mol. Sci.20212218999610.3390/ijms22189996 34576159
     [Google Scholar]
  8. GobbiG. ComaiS. Differential function of melatonin MT1 and MT2 receptors in REM and NREM Sleep.Front. Endocrinol. (Lausanne)2019108710.3389/fendo.2019.00087 30881340
     [Google Scholar]
  9. PandiperumalS. TrakhtI. SrinivasanV. SpenceD. MaestroniG. ZisapelN. CardinaliD. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways.Prog. Neurobiol.200885333535310.1016/j.pneurobio.2008.04.001 18571301
     [Google Scholar]
  10. KlosenP. LapmaneeS. SchusterC. GuardiolaB. HicksD. PevetP. Felder-SchmittbuhlM.P. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.J. Pineal Res.2019671e1257510.1111/jpi.12575 30937953
     [Google Scholar]
  11. ComaiS. Ochoa-SanchezR. GobbiG. Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice.Behav. Brain Res.201324323123810.1016/j.bbr.2013.01.008 23333399
     [Google Scholar]
  12. LiuJ. CloughS.J. HutchinsonA.J. Adamah-BiassiE.B. Popovska-GorevskiM. DubocovichM.L. MT1 and MT2 melatonin receptors: A therapeutic perspective.Annu. Rev. Pharmacol. Toxicol.201656136138310.1146/annurev‑pharmtox‑010814‑124742 26514204
     [Google Scholar]
  13. DubocovichM.L. HudsonR.L. SumayaI.C. MasanaM.I. MannaE. Effect of MT1 melatonin receptor deletion on melatonin‐mediated phase shift of circadian rhythms in the C57BL/6 mouse.J. Pineal Res.200539211312010.1111/j.1600‑079X.2005.00230.x 16098087
     [Google Scholar]
  14. Falup-PecurariuC. DiaconuȘ. ȚînțD. Falup-PecurariuO. Neurobiology of sleep.Exp. Ther. Med.2021213272 33603879
     [Google Scholar]
  15. VaniniG. TorteroloP. Sleep-wake neurobiology.Adv. Exp. Med. Biol.20211297658210.1007/978‑3‑030‑61663‑2_5
     [Google Scholar]
  16. ReichertC.F. DeboerT. LandoltH.P. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives.J. Sleep Res.2022314e1359710.1111/jsr.13597 35575450
     [Google Scholar]
  17. ChaturvediR. EmeryP. Fly into tranquility: GABA’s role in drosophila sleep.Curr. Opin. Insect Sci.20246410121910.1016/j.cois.2024.101219 38848811
     [Google Scholar]
  18. TakahashiJ.S. Finding new clock components: Past and future.J. Biol. Rhythms200419533934710.1177/0748730404269151 15536063
     [Google Scholar]
  19. TorrealbaF. YanagisawaM. SaperC.B. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats.Neuroscience200311941033104410.1016/S0306‑4522(03)00238‑0 12831862
     [Google Scholar]
  20. VaniniG. BassanaM. MastM. MondinoA. CerdaI. PhyleM. ChenV. ColmeneroA.V. Hambrecht-WiedbuschV.S. MashourG.A. Activation of preoptic GABAergic or glutamatergic neurons modulates sleep-wake architecture, but not anesthetic state transitions.Curr. Biol.2020305779787.e410.1016/j.cub.2019.12.063 32084397
     [Google Scholar]
  21. RosensteinR.E. CardinaliD.P. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland.Brain Res.1986398240340610.1016/0006‑8993(86)91505‑2 3801913
     [Google Scholar]
  22. MonnetF.P. Melatonin modulates [3h]serotonin release in the rat hippocampus: Effects of circadian rhythm.J. Neuroendocrinol.200214319419910.1046/j.0007‑1331.2001.00761.x 11999718
     [Google Scholar]
  23. SharmaR. SahotaP. ThakkarM.M. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus.J. Pineal Res.2018652e1249810.1111/jpi.12498 29654707
     [Google Scholar]
  24. HolbrookA. CrowtherR. LotterA. EndeshawY. The role of benzodiazepines in the treatment of insomnia: meta-analysis of benzodiazepine use in the treatment of insomnia.J. Am. Geriatr. Soc.200149682482610.1046/j.1532‑5415.2001.49161.x 11454123
     [Google Scholar]
  25. MiP. GaoQ. FengZ.Y. ZhangJ.W. ZhaoX. ChenD.Y. FengX.Z. Melatonin attenuates 17β-trenbolone induced insomnia-like phenotype and movement deficiency in zebrafish.Chemosphere202025312676210.1016/j.chemosphere.2020.126762 32302915
     [Google Scholar]
  26. RobinsonC.L. SupraR. DownsE. KatariaS. ParkerK. KayeA.D. ViswanathO. UritsI. Daridorexant for the treatment of insomnia.Health Psychol. Res.20221033740010.52965/001c.37400 36045942
     [Google Scholar]
  27. OzdemirP.G. KaradagA.S. SelviY. BoysanM. BilgiliS.G. AydinA. OnderS. Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.Int. J. Psychiatry Clin. Pract.201418316116810.3109/13651501.2014.907919 24673474
     [Google Scholar]
  28. BrzezinskiA. VangelM.G. WurtmanR.J. NorrieG. ZhdanovaI. Ben-ShushanA. FordI. Effects of exogenous melatonin on sleep: A meta-analysis.Sleep Med. Rev.200591415010.1016/j.smrv.2004.06.004 15649737
     [Google Scholar]
  29. Ferracioli-OdaE. QawasmiA. BlochM.H. Meta-analysis: Melatonin for the treatment of primary sleep disorders.PLoS One201385e6377310.1371/journal.pone.0063773 23691095
     [Google Scholar]
  30. AuldF. MaschauerE.L. MorrisonI. SkeneD.J. RihaR.L. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders.Sleep Med. Rev.201734102210.1016/j.smrv.2016.06.005 28648359
     [Google Scholar]
  31. Cruz-SanabriaF. BrunoS. CrippaA. FrumentoP. ScarselliM. SkeneD.J. FaragunaU. Optimizing the time and dose of melatonin as a sleep‐promoting drug: A systematic review of randomized controlled trials and dose-response meta‐analysis.J. Pineal Res.2024765e1298510.1111/jpi.12985 38888087
     [Google Scholar]
  32. Cruz-AguilarM.A. Ramírez-SaladoI. GuevaraM.A. Hernández-GonzálezM. Benitez-KingG. Melatonin effects on EEG activity during sleep onset in mild-to-moderate alzheimer’s disease: A pilot study.J. Alzheimers Dis. Rep.201821556510.3233/ADR‑170019 30480249
     [Google Scholar]
  33. MaH. YanJ. SunW. JiangM. ZhangY. Melatonin treatment for sleep disorders in parkinson’s disease: A meta-analysis and systematic review.Front. Aging Neurosci.20221478431410.3389/fnagi.2022.784314 35185525
     [Google Scholar]
  34. WangL. PanY. YeC. GuoL. LuoS. DaiS. ChenN. WangE. A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults.Neurosci. Biobehav. Rev.202113148949610.1016/j.neubiorev.2021.09.035 34560134
     [Google Scholar]
  35. De CrescenzoF. D’AlòG.L. OstinelliE.G. CiabattiniM. Di FrancoV. WatanabeN. KurtulmusA. TomlinsonA. MitrovaZ. FotiF. Del GiovaneC. QuestedD.J. CowenP.J. BarbuiC. AmatoL. EfthimiouO. CiprianiA. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: A systematic review and network meta-analysis.Lancet20224001034717018410.1016/S0140‑6736(22)00878‑9 35843245
     [Google Scholar]
  36. VigoD.E. CardinaliD.P. Melatonin and Benzodiazepine/Z-Drug Abuse.Psychiatry and Neuroscience Update.ChamSpringer International Publishing201942745110.1007/978‑3‑319‑95360‑1_34
     [Google Scholar]
  37. CardinaliD.P. GolombekD.A. RosensteinR.E. BruscoL.I. VigoD.E. Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.Pharmacol. Res.2016109122310.1016/j.phrs.2015.08.016 26438969
     [Google Scholar]
  38. IftikharS. SameerH.M. Zainab, Significant potential of melatonin therapy in Parkinson’s disease: A meta-analysis of randomized controlled trials.Front. Neurol.202314126578910.3389/fneur.2023.1265789 37881313
     [Google Scholar]
  39. Barbosa-MéndezS. Pérez-SánchezG. Becerril-VillanuevaE. Salazar-JuárezA. Melatonin decreases cocaine-induced locomotor sensitization and cocaine-conditioned place preference in rats.J. Psychiatr. Res.20211329711010.1016/j.jpsychires.2020.09.027 33080430
     [Google Scholar]
  40. KastnerM. TriccoA.C. SoobiahC. LillieE. PerrierL. HorsleyT. WelchV. CogoE. AntonyJ. StrausS.E. What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review.BMC Med. Res. Methodol.201212111410.1186/1471‑2288‑12‑114 22862833
     [Google Scholar]
  41. ArkseyH. O’MalleyL. Scoping studies: Towards a methodological framework.Int. J. Soc. Res. Methodol.200581193210.1080/1364557032000119616
     [Google Scholar]
  42. LevacD. ColquhounH. O’BrienK.K. Scoping studies: Advancing the methodology.Implement. Sci.2010516910.1186/1748‑5908‑5‑69 20854677
     [Google Scholar]
  43. ColquhounH.L. LevacD. O’BrienK.K. StrausS. TriccoA.C. PerrierL. KastnerM. MoherD. Scoping reviews: Time for clarity in definition, methods, and reporting.J. Clin. Epidemiol.201467121291129410.1016/j.jclinepi.2014.03.013 25034198
     [Google Scholar]
  44. Peters, m.; Godfrey, Q.M.; Mcinerney, P. Scoping reviews.JBI Manual for Evidence Synthesis.Adelaide, AustraliaJBI2020
     [Google Scholar]
  45. TriccoA.C. LillieE. ZarinW. O’BrienK.K. ColquhounH. LevacD. MoherD. PetersM.D.J. HorsleyT. WeeksL. HempelS. AklE.A. ChangC. McGowanJ. StewartL. HartlingL. AldcroftA. WilsonM.G. GarrittyC. LewinS. GodfreyC.M. MacdonaldM.T. LangloisE.V. Soares-WeiserK. MoriartyJ. CliffordT. TunçalpÖ. StrausS.E. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation.Ann. Intern. Med.2018169746747310.7326/M18‑0850 30178033
     [Google Scholar]
  46. LowensteinP.R. RosensteinR. CardinaliD.P. Melatonin reverses pinealectomy-induced decrease of benzodiazepine binding in rat cerebral cortex.Neurochem. Int.19857467568110.1016/0197‑0186(85)90065‑8 20492974
     [Google Scholar]
  47. YangH.J. KimM.J. KimS.S. ChoY.W. Melatonin modulates nitric oxide-regulated WNK-SPAK/OSR1-NKCC1 signaling in dorsal raphe nucleus of rats.Korean J. Physiol. Pharmacol.202125544945710.4196/kjpp.2021.25.5.449 34448462
     [Google Scholar]
  48. ChengX.P. SunH. YeZ.Y. ZhouJ.N. Melatonin modulates the GABAergic response in cultured rat hippocampal neurons.J. Pharmacol. Sci.2012119217718510.1254/jphs.11183FP 22673185
     [Google Scholar]
  49. CastroviejoA. RosensteinR.E. RomeoH.E. CardinaliD.P. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats.Neuroendocrinology1986431243110.1159/000124504 3713987
     [Google Scholar]
  50. HongS.I. KwonS.H. HwangJ.Y. MaS.X. SeoJ.Y. KoY.H. KimH.C. LeeS.Y. JangC.G. Quinpirole increases melatonin-augmented pentobarbital sleep via cortical ERK, p38 MAPK, and PKC in mice.Biomol. Ther. (Seoul)201624211512210.4062/biomolther.2015.097 26902082
     [Google Scholar]
  51. HuangY. LiY. LengZ. Melatonin inhibits GABAergic neurons in the hypothalamus consistent with a reduction in wakefulness.Neuroreport2020312929810.1097/WNR.0000000000001374 31876681
     [Google Scholar]
  52. Ochoa-SanchezR. ComaiS. LacosteB. BambicoF.R. Dominguez-LopezS. SpadoniG. RivaraS. BediniA. AngeloniD. FraschiniF. MorM. TarziaG. DescarriesL. GobbiG. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand.J. Neurosci.20113150184391845210.1523/JNEUROSCI.2676‑11.2011 22171046
     [Google Scholar]
  53. KumarA. SinghA. Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation–induced behaviour modification and oxidative damage in mice.Fundam. Clin. Pharmacol.200923443944810.1111/j.1472‑8206.2009.00737.x 19709322
     [Google Scholar]
  54. LangebartelsA. MathiasS. LancelM. Acute effects of melatonin on spontaneous and picrotoxin‐evoked sleep-wake behaviour in the rat.J. Sleep Res.200110321121710.1046/j.1365‑2869.2001.00257.x 11696074
     [Google Scholar]
  55. LevesqueT.R. LockeK.W. Discriminative stimulus effects of melatonin in the rat.Psychopharmacology (Berl.)1994116216717210.1007/BF02245059 7862946
     [Google Scholar]
  56. WangF. LiJ. WuC. YangJ. XuF. ZhaoQ. The GABAA receptor mediates the hypnotic activity of melatonin in rats.Pharmacol. Biochem. Behav.200374357357810.1016/S0091‑3057(02)01045‑6 12543221
     [Google Scholar]
  57. KolkerD.E. Losee OlsonS. Dutton-BoilekJ. BennettK.M. WallenE.P. HortonT.H. TurekF.W. Feeding melatonin enhances the phase shifting response to triazolam in both young and old golden hamsters.Am. J. Physiol. Regul. Integr. Comp. Physiol.20022825R1382R138810.1152/ajpregu.00362.2001 11959680
     [Google Scholar]
  58. BorsaniE. BonominiF. BoniniS.A. PremoliM. MaccarinelliG. GiugnoL. MastinuA. AriaF. MemoM. RezzaniR. Role of melatonin in autism spectrum disorders in a male murine transgenic model: Study in the prefrontal cortex.J. Neurosci. Res.2022100378079710.1002/jnr.24997 35043490
     [Google Scholar]
  59. MatsutaY. YusupA. TanaseK. IshidaH. AkinoH. YokoyamaO. Melatonin increases bladder capacity via GABAergic system and decreases urine volume in rats.J. Urol.2010184138639110.1016/j.juro.2010.03.002 20488476
     [Google Scholar]
  60. XuZ. LiW. SunY. JinW. YuL. YangJ. WangQ. Melatonin alleviates PTSD-like behaviors and restores serum GABA and cortisol levels in mice.Psychopharmacology (Berl.)2023240225926910.1007/s00213‑023‑06312‑y 36642730
     [Google Scholar]
  61. ZhangL. GuoH.L. ZhangH.Q. XuT.Q. HeB. WangZ.H. YangY.P. TangX.D. ZhangP. LiuF.E. Melatonin prevents sleep deprivation-associated anxiety-like behavior in rats: Role of oxidative stress and balance between GABAergic and glutamatergic transmission.Am. J. Transl. Res.20179522312242 28559974
     [Google Scholar]
  62. Ferini-StrambiL. ZucconiM. BiellaG. StankovB. FraschiniF. OldaniA. SmirneS. Effect of melatonin on sleep microstructure: Preliminary results in healthy subjects.Sleep199316874474710.1093/sleep/16.8.744 8165389
     [Google Scholar]
  63. DjeridaneY. TouitouY. Effects of diazepam and its metabolites on nocturnal melatonin secretion in the rat pineal and Harderian glands. A comparative in vivo and in vitro study.Chronobiol. Int.200320228529710.1081/CBI‑120018579 12723886
     [Google Scholar]
  64. NoguchiH. KitazumiK. MoriM. ShiobaraY. ShibaT. Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits.J. Pharmacol. Sci.200393220420910.1254/jphs.93.204 14578589
     [Google Scholar]
  65. MannK. BauerH. HiemkeC. RöschkeJ. WetzelH. BenkertO. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion.Eur. Neuropsychopharmacol.19966316316810.1016/0924‑977X(96)00014‑4 8880074
     [Google Scholar]
  66. HajakG. RodenbeckA. BandelowB. FriedrichsS. HuetherG. RütherE. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects.Eur. Neuropsychopharmacol.19966214915310.1016/0924‑977X(96)00005‑3 8791041
     [Google Scholar]
  67. MoreraA.L. Abreu-GonzalezP. HenryM. Zaleplon increases nocturnal melatonin secretion in humans.Prog. Neuropsychopharmacol. Biol. Psychiatry20093361013101610.1016/j.pnpbp.2009.05.011 19463883
     [Google Scholar]
  68. AtsmonJ. OakninS. LaudonM. LaschinerS. GavishM. DaganY. ZisapelN. Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites.J. Pineal Res.1996202657110.1111/j.1600‑079X.1996.tb00241.x 8815189
     [Google Scholar]
  69. BassaniT.B. GradowskiR.W. ZaminelliT. BarbieroJ.K. SantiagoR.M. BoschenS.L. da CunhaC. LimaM.M.S. AndreatiniR. VitalM.A.B.F. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson’s disease model in rats.Brain Res.201415939510510.1016/j.brainres.2014.09.068 25301688
     [Google Scholar]
  70. MuneokaK. OgawaT. TakigawaM. Effects of neonatal melatonin administration on the extra-hypothalamic regions in rat brains: Effects on the serotonergic system.Neurochem. Res.200025681782210.1023/A:1007517524179 10944000
     [Google Scholar]
  71. PazoD. CardinaliD.P. CanoP. Reyes TosoC.A. EsquifinoA.I. Age-related changes in 24-hour rhythms of norepinephrine content and serotonin turnover in rat pineal gland: effect of melatonin treatment.Neurosignals2002112818710.1159/000058544 12077481
     [Google Scholar]
  72. IyengarB. Indoleamines and the UV-light-sensitive photoperiodic responses of the melanocyte network: A biological calendar?Experientia199450873373610.1007/BF01919373 8070534
     [Google Scholar]
  73. ChenuF. ShimS. El MansariM. BlierP. Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons.J. Psychopharmacol.201428216216710.1177/0269881113510071 24189440
     [Google Scholar]
  74. OxenkrugG.F. RequintinaP.J. Melatonin and jet lag syndrome: Experimental model and clinical implications.CNS Spectr.20038213914810.1017/S109285290001837X 12612500
     [Google Scholar]
  75. ParedesS.D. TerrónM.P. ValeroV. BarrigaC. ReiterR.J. RodríguezA.B. Orally administered melatonin improves nocturnal rest in young and old ringdoves (Streptopelia risoria).Basic Clin. Pharmacol. Toxicol.2007100425826810.1111/j.1742‑7843.2006.00032.x 17371530
     [Google Scholar]
  76. ParedesS.D. MarchenaA.M. BejaranoI. EspinoJ. BarrigaC. RialR.V. ReiterR.J. RodríguezA.B. Melatonin and tryptophan affect the activity-rest rhythm, core and peripheral temperatures, and interleukin levels in the ringdove: Changes with age.J. Gerontol. A Biol. Sci. Med. Sci.200964A334035010.1093/gerona/gln054 19211547
     [Google Scholar]
  77. HaduchA. BromekE. WójcikowskiJ. GołembiowskaK. DanielW.A. Melatonin supports CYP2D-mediated serotonin synthesis in the brain.Drug Metab. Dispos.201644344545210.1124/dmd.115.067413 26884482
     [Google Scholar]
  78. DugovicC. LeysenJ.E. WauquierA. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep—wakefulness regulation in the rat.Neurosci. Lett.1989104332032510.1016/0304‑3940(89)90596‑X 2510097
     [Google Scholar]
  79. JagotaA. KalyaniD. Effect of melatonin on age induced changes in daily serotonin rhythms in suprachiasmatic nucleus of male Wistar rat.Biogerontology201011329930810.1007/s10522‑009‑9248‑9 19774481
     [Google Scholar]
  80. PoceviciuteI. BuisasR. RuksenasO. VengelieneV. Melatonin reduces alcohol drinking in rats with disrupted function of the serotonergic system.J. Pers. Med.202212335510.3390/jpm12030355 35330355
     [Google Scholar]
  81. WangY. WangX. ChenJ. LiS. ZhaiH. WangZ. Melatonin pretreatment attenuates acute methamphetamine-induced aggression in male ICR mice.Brain Res.2019171519620210.1016/j.brainres.2019.04.002 30953606
     [Google Scholar]
  82. SchillerE.D. ChampneyT.H. ReiterC.K. DohrmanD.P. Melatonin inhibition of nicotine-stimulated dopamine release in PC12 cells.Brain Res.200396619510210.1016/S0006‑8993(02)04200‑2 12646312
     [Google Scholar]
  83. HolmesS.W. SugdenD. Effects of melatonin on sleep and neurochemistry in the rat.Br. J. Pharmacol.19827619510110.1111/j.1476‑5381.1982.tb09194.x 7082909
     [Google Scholar]
  84. MatsumotoT. DucsayC.A. Maternal plasma catecholamines in the rhesus macaque during late gestation: Effect of photoperiod and timed melatonin infusion.Biol. Reprod.199247458258710.1095/biolreprod47.4.582 1391345
     [Google Scholar]
  85. ZhdanovaI.V. GiorgettiM. Melatonin alters behavior and cAMP levels in nucleus accumbens induced by cocaine treatment.Brain Res.2002956232333110.1016/S0006‑8993(02)03565‑5 12445702
     [Google Scholar]
  86. Aranda-MartínezP. Fernández-MartínezJ. Ramírez-CasasY. Rodríguez-SantanaC. RusanovaI. EscamesG. Acuña-CastroviejoD. Chronodisruption and loss of melatonin rhythm, associated with alterations in daily motor activity and mitochondrial dynamics in parkinsonian zebrafish, are corrected by melatonin treatment.Antioxidants202312495410.3390/antiox12040954 37107331
     [Google Scholar]
  87. SumayaI.C. DubocovichM.L. Melatonin-mediated attenuation of fluphenazine-induced hypokinesia in C57BL/6 mice is dependent on the light/dark phase.Behav. Brain Res.202242511382710.1016/j.bbr.2022.113827 35248650
     [Google Scholar]
  88. HussainS. VillarrealS. RamirezN. HussainA. SumayaI.C. Haloperidol-induced hypokinesia in rats is differentially affected by the light/dark phase, age, and melatonin.Behav. Brain Res.202037911231310.1016/j.bbr.2019.112313 31715211
     [Google Scholar]
  89. VotawV.R. GeyerR. RieselbachM.M. McHughR.K. The epidemiology of benzodiazepine misuse: A systematic review.Drug Alcohol Depend.20192009511410.1016/j.drugalcdep.2019.02.033 31121495
     [Google Scholar]
  90. MachadoN.L.S. ToddW.D. KaurS. SaperC.B. Median preoptic GABA and glutamate neurons exert differential control over sleep behavior.Curr. Biol.202232920112021.e310.1016/j.cub.2022.03.039 35385692
     [Google Scholar]
  91. EvelyK.M. HudsonR.L. DubocovichM.L. Haj-dahmaneS. Melatonin receptor activation increases glutamatergic synaptic transmission in the rat medial lateral habenula.Synapse201670518118610.1002/syn.21892 26799638
     [Google Scholar]
  92. TarditoD. MilaneseM. BonifacinoT. MusazziL. GrilliM. MalleiA. MocaerE. Gabriel-GraciaC. RacagniG. PopoliM. BonannoG. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways.BMC Neurosci.20101116810.1186/1471‑2202‑11‑68 20525261
     [Google Scholar]
  93. MaoK. LuoP. GengW. XuJ. LiaoY. ZhongH. MaP. TanQ. XiaH. DuanL. SongS. LongD. LiuY. YangT. WuY. JinY. An integrative transcriptomic and metabolomic study revealed that melatonin plays a protective role in chronic lung inflammation by reducing necroptosis.Front. Immunol.20211266800210.3389/fimmu.2021.668002 34017341
     [Google Scholar]
  94. ZhaoH. ZhangT. ZhangH. WangY. ChengL. Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke.Neural Regen. Res.20241961336134310.4103/1673‑5374.385844 37905883
     [Google Scholar]
  95. ChuluyanH.E. RosensteinR.E. ChangS.M. GálvezM.M. CardinaliD.P. Presynaptic effects of melatonin on norepinephrine release and uptake in rat pineal gland.J. Pineal Res.199110416517310.1111/j.1600‑079X.1991.tb00811.x 1681046
     [Google Scholar]
  96. BruscoL.I. García-BonachoM. EsquifinoA.I. CardinaliD.P. Diurnal rhythms in norepinephrine and acetylcholine synthesis of sympathetic ganglia, heart and adrenals of aging rats: Effect of melatonin.J. Auton. Nerv. Syst.1998741496110.1016/S0165‑1838(98)00134‑9 9858124
     [Google Scholar]
  97. AppelbaumL. WangG.X. MaroG.S. MoriR. TovinA. MarinW. YokogawaT. KawakamiK. SmithS.J. GothilfY. MignotE. MourrainP. Sleep-wake regulation and hypocretin-melatonin interaction in zebrafish.Proc. Natl. Acad. Sci. USA200910651219422194710.1073/pnas.906637106 19966231
     [Google Scholar]
  98. AppelbaumL. WangG. YokogawaT. SkariahG.M. SmithS.J. MourrainP. MignotE. Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons.Neuron2010681879810.1016/j.neuron.2010.09.006 20920793
     [Google Scholar]
  99. SehzadeS. KocC. KahveciN. Melatonin treatment affects leptin and nesfatin-1 levels but not orexin: A levels in REM sleep deprived rats.Kafkas Univ. Vet. Fak. Derg.20232953754410.9775/kvfd.2023.29955
     [Google Scholar]
  100. GottJ.A. StückerS. KanskeP. HaakerJ. DreslerM. Acetylcholine and metacognition during sleep.Conscious. Cogn.202411710360810.1016/j.concog.2023.103608 38042119
     [Google Scholar]
  101. CardinaliD.P. BruscoL.I. GarcíaB.M. EsquifìnoA.I. Effect of melatonin on 24-hour rhythms of ornithine decarboxylase activity and norepinephrine and acetylcholine synthesis in submaxillary lymph nodes and spleen of young and aged rats.Neuroendocrinology199867534936210.1159/000054333 9641617
     [Google Scholar]
  102. de PradoB.M. ReiterR.J. MoraF. Perfusion of melatonin into the prefrontal cortex disrupts the circadian rhythm of acetylcholine but not of locomotor activity.J. Pineal Res.200335428328710.1034/j.1600‑079X.2003.00088.x 14521635
     [Google Scholar]
  103. TanchevaL. LazarovaM. SasoL. KalfinR. StefanovaM. UzunovaD. AtanasovA.G. Beneficial effect of melatonin on motor and memory disturbances in 6-OHDA-Lesioned rats.J. Mol. Neurosci.202171470271210.1007/s12031‑020‑01760‑z 33403591
     [Google Scholar]
  104. von GallC. GarabetteM.L. KellC.A. FrenzelS. DehghaniF. Schumm-DraegerP.M. WeaverD.R. KorfH.W. HastingsM.H. StehleJ.H. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin.Nat. Neurosci.20025323423810.1038/nn806 11836530
     [Google Scholar]
  105. ZamorskiiI.I. Effect of melatonin on the intensity of adenosine production in the rat forebrain under conditions of acute hypoxia and varied photoperiodicity.Neurophysiology2003351444710.1023/A:1023998306826
     [Google Scholar]
  106. CaoJ. RibelaygaC.P. MangelS.C. A circadian clock in the retina regulates rod-cone gap junction coupling and neuronal light responses via activation of adenosine A2A receptors.Front. Cell. Neurosci.20211460506710.3389/fncel.2020.605067 33510619
     [Google Scholar]
  107. BannaiM. KawaiN. New therapeutic strategy for amino acid medicine: Glycine improves the quality of sleep.J. Pharmacol. Sci.2012118214514810.1254/jphs.11R04FM 22293292
     [Google Scholar]
  108. MaY. MiraccaG. YuX. HardingE.C. MiaoA. YustosR. VyssotskiA.L. FranksN.P. WisdenW. Galanin neurons unite sleep homeostasis and α2-adrenergic sedation.Curr. Biol.2019291933153322.e310.1016/j.cub.2019.07.087 31543455
     [Google Scholar]
  109. TaheriP. MogheisehA. ShojaeeT.A. NazifiS. SalavatiS. KoohiF. Changes in thyroid hormones, leptin, ghrelin and, galanin following oral melatonin administration in intact and castrated dogs: A preliminary study.BMC Vet. Res.201915114510.1186/s12917‑019‑1894‑9 31088464
     [Google Scholar]
  110. ThakkarM.M. Histamine in the regulation of wakefulness.Sleep Med. Rev.2011151657410.1016/j.smrv.2010.06.004 20851648
     [Google Scholar]
  111. BurgazliC.R. RanaK.B. BrownJ.N. TillmanF. Efficacy and safety of hydroxyzine for sleep in adults: Systematic review.Hum. Psychopharmacol.2023382e286410.1002/hup.2864 36843057
     [Google Scholar]
  112. DolderC.R. NelsonM.H. IlerC.A. The effects of mirtazapine on sleep in patients with major depressive disorder.Ann. Clin. Psychiatry2012243215224 22860241
     [Google Scholar]
  113. DijkD.J. RothC. LandoltH.P. WerthE. AeppliM. AchermannP. BorbélyA.A. Melatonin effect on daytime sleep in men: Suppression of EEG low frequency activity and enhancement of spindle frequency activity.Neurosci. Lett.19952011131610.1016/0304‑3940(95)12118‑N 8830301
     [Google Scholar]
  114. FernandezL.M.J. LüthiA. Sleep spindles: Mechanisms and functions.Physiol. Rev.2020100280586810.1152/physrev.00042.2018 31804897
     [Google Scholar]
  115. YuX. LiW. MaY. TossellK. HarrisJ.J. HardingE.C. BaW. MiraccaG. WangD. LiL. GuoJ. ChenM. LiY. YustosR. VyssotskiA.L. BurdakovD. YangQ. DongH. FranksN.P. WisdenW. GABA and glutamate neurons in the VTA regulate sleep and wakefulness.Nat. Neurosci.201922110611910.1038/s41593‑018‑0288‑9 30559475
     [Google Scholar]
  116. ManconiM. FerriR. MianoS. MaestriM. BottasiniV. ZucconiM. Ferini-StrambiL. Sleep architecture in insomniacs with severe benzodiazepine abuse.Clin. Neurophysiol.2017128687588110.1016/j.clinph.2017.03.009 28399441
     [Google Scholar]
  117. SigelE. ErnstM. The benzodiazepine binding sites of GABAA receptors.Trends Pharmacol. Sci.201839765967110.1016/j.tips.2018.03.006 29716746
     [Google Scholar]
  118. ZiemichódW. GrabowskaK. KurowskaA. BiałaG. A comprehensive review of daridorexant, a dual-orexin receptor antagonist as new approach for the treatment of insomnia.Molecules20222718604110.3390/molecules27186041 36144776
     [Google Scholar]
  119. GuanQ. WangZ. CaoJ. DongY. ChenY. Mechanisms of melatonin in obesity: A review.Int. J. Mol. Sci.202123121810.3390/ijms23010218 35008644
     [Google Scholar]
  120. SuriyagandhiV. NachiappanV. Protective effects of melatonin against obesity‐induced by leptin resistance.Behav. Brain Res.202241711359810.1016/j.bbr.2021.113598 34563600
     [Google Scholar]
  121. JonesB.E. Arousal and sleep circuits.Neuropsychopharmacology202045162010.1038/s41386‑019‑0444‑2 31216564
     [Google Scholar]
  122. GreenlundI.M. CarterJ.R. Sympathetic neural responses to sleep disorders and insufficiencies.Am. J. Physiol. Heart Circ. Physiol.20223223H337H34910.1152/ajpheart.00590.2021 34995163
     [Google Scholar]
  123. PhamL. BaiocchiL. KennedyL. SatoK. MeadowsV. MengF. HuangC.K. KunduD. ZhouT. ChenL. AlpiniG. FrancisH. The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators.J. Pineal Res.2021702e1269910.1111/jpi.12699 33020940
     [Google Scholar]
  124. MarsegliaL. D’AngeloG. MantiS. SalpietroC. ArrigoT. BarberiI. ReiterR. GittoE. Melatonin and atopy: Role in atopic dermatitis and asthma.Int. J. Mol. Sci.2014158134821349310.3390/ijms150813482 25093714
     [Google Scholar]
  125. TanK.R. BrownM. LabouèbeG. YvonC. CretonC. FritschyJ.M. RudolphU. LüscherC. Neural bases for addictive properties of benzodiazepines.Nature2010463728276977410.1038/nature08758 20148031
     [Google Scholar]
  126. BesagF.M.C. VaseyM.J. LaoK.S.J. WongI.C.K. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: A systematic review.CNS Drugs201933121167118610.1007/s40263‑019‑00680‑w 31722088
     [Google Scholar]
  127. FoleyH.M. SteelA.E. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence.Complement. Ther. Med.201942658110.1016/j.ctim.2018.11.003 30670284
     [Google Scholar]
  128. OtmaniS. DemazièresA. StanerC. JacobN. NirT. ZisapelN. StanerL. Effects of prolonged‐release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.Hum. Psychopharmacol.200823869370510.1002/hup.980 18763235
     [Google Scholar]
  129. GiovanniniS. OnderG. van der RoestH.G. TopinkovaE. GindinJ. CiprianiM.C. DenkingerM.D. BernabeiR. LiperotiR. Use of antidepressant medications among older adults in European long-term care facilities: A cross-sectional analysis from the SHELTER study.BMC Geriatr.202020131010.1186/s12877‑020‑01730‑5 32854659
     [Google Scholar]
  130. FosterB.C. CvijovicK. BoonH.S. TamT.W. LiuR. MurtyM. VuD. JaegerW. TsuyukiR.T. BarnesJ. VohraS. Melatonin interaction resulting in severe sedation.J. Pharm. Pharm. Sci.201518212413110.18433/J3SS35 26158279
     [Google Scholar]
  131. TuftC. MatarE. Menczel SchrireZ. GrunsteinR.R. YeeB.J. HoyosC.M. Current insights into the risks of using melatonin as a treatment for sleep disorders in older adults.Clin. Interv. Aging202318495910.2147/CIA.S361519 36660543
     [Google Scholar]
  132. Rzepka-MigutB. PaprockaJ. Efficacy and safety of melatonin treatment in children with autism spectrum disorder and attention-deficit/hyperactivity disorder: A review of the literature.Brain Sci.202010421910.3390/brainsci10040219 32272607
     [Google Scholar]
  133. Menczel SchrireZ. PhillipsC.L. ChapmanJ.L. DuffyS.L. WongG. D’RozarioA.L. ComasM. RaisinI. SainiB. GordonC.J. McKinnonA.C. NaismithS.L. MarshallN.S. GrunsteinR.R. HoyosC.M. Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis.J. Pineal Res.2022722e1278210.1111/jpi.12782 34923676
     [Google Scholar]
  134. MoroniI. Garcia-BennettA. ChapmanJ. GrunsteinR.R. GordonC.J. ComasM. Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: A systematic review.Sleep Med. Rev.20215710143110.1016/j.smrv.2021.101431 33549911
     [Google Scholar]
  135. SavocaA. MancaD. Physiologically-based pharmacokinetic simulations in pharmacotherapy: Selection of the optimal administration route for exogenous melatonin.ADMET DMPK201971445910.5599/admet.625 35350746
     [Google Scholar]
  136. ZetnerD. AndersenL.P. RosenbergJ. Pharmacokinetics of alternative administration routes of melatonin: A systematic review.Drug Res. (Stuttg.)2016664169173 26514093
     [Google Scholar]
  137. ParedesD. RadaP. BonillaE. GonzalezL.E. ParadaM. HernandezL. Melatonin acts on the nucleus accumbens to increase acetylcholine release and modify the motor activity pattern of rats.Brain Res.19998501-2142010.1016/S0006‑8993(99)01992‑7 10629744
     [Google Scholar]
/content/journals/cn/10.2174/011570159X379708250702084616
Loading
Exogenous Melatonin as a Sleep-promoting Agent beyond its Chronobiotic Properties: A Scoping Review of its Effects on Key Sleep-wake Neurotransmitters
Curr. Neuropharmacol. 24, 364 (2026); https://doi.org/10.2174/011570159X379708250702084616
/content/journals/cn/10.2174/011570159X379708250702084616
/content/journals/cn/10.2174/011570159X379708250702084616
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Melatonin; sleep; sleep disorders; sleep medicine; sleep-promoting agent; sleep-wake neurotransmitters

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test